Review Note
Last Update: 01/27/2025 03:38 AM
Current Deck: A Villanova CRNA::Advanced Pharmacology Class::Exam 1
PublishedCurrently Published Content
Text
"Phase 4" = In the post-marketing period
(after they get approved by FDA), drugs are monitored for {{c1::adverse events}} (sometimes ones that happen less freq but now you have so many more people taking drug)
- Important for populations not included in premarketing trials
- {{c1::Kids, preggos, old people::3 big populations}}
- Important for long term mortality & morbidity profile
Extra
- Rare adverse effects (<1 in 1000) not reliable until >100k+ people took it
No published tags.
Pending Suggestions
No pending suggestions for this note.